STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #4148 by analyst upside · 2026-08-08
ATTO
Attovia Therapeutics, Inc. Common Stock
Unknown · Market Cap N/A · P/E 0x
ANALYST PRICE TARGET
-25.6%
implied upside to consensus target
Current Price $20.17
Consensus Target $15.0
Bull Target $15.0
Bear Target $15.0
Analysts Covering 1
ANALYST CONSENSUS - UNDERPERFORM
Strong Buy
0
Buy
0
Hold
0
Sell
1
52-Week Low $18.64
52-Week High $20.94
YTD Return +0.0%
FUNDAMENTALS
Market Cap N/A
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) N/A
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) N/A
Profit Margin N/A
52-WEEK RANGE
52-Week Low $18.64
52-Week High $20.94
Current Price $20.17
Bear Target $15.0
Bull Target $15.0
● Now $20.17 ● Target $15.0
TRADING DATA
Avg Volume N/A
YTD Return +0.0%
Analyst Count 1
Consensus Underperform
Upside to Target -25.6%
Last Updated 2026-08-08

ANALYST SUMMARY

Attovia Therapeutics, Inc. Common Stock (ATTO) is currently trading at $20.17 with a Wall Street consensus price target of $15.0, which is 25.6% below the current price over the next 12 months. 1 analysts currently cover ATTO, with a consensus rating of Underperform - 0% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $15.0, while the most cautious has a target of $15.0.

ATTO operates in the Unknown sector with a market capitalisation of N/A. The stock is up 0.0% year-to-date and is currently trading near the upper end of its 52-week range of $18.64 – $20.94.

HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
15
out of 100
Coverage depth
5/30
Consensus clarity
8/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →